Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $0.75 and last traded at $0.60, with a volume of 20266379 shares trading hands. The stock had previously closed at $0.71.
Elite Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.09 and a current ratio of 3.08. The company has a market capitalization of $502.30 million, a price-to-earnings ratio of 47.02 and a beta of 0.19. The company has a 50-day moving average price of $0.36 and a 200-day moving average price of $0.23.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Further Reading
- Five stocks we like better than Elite Pharmaceuticals
- 3 Fintech Stocks With Good 2021 Prospects
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Breakout Stocks: What They Are and How to Identify Them
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- About the Markup Calculator
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
